1. "2018"
Formats
  1. Journal Article (3007)
  2. Meeting Abstract (1947)
  3. Book Section (205)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (3)
  7. Correspondence (1)
  8. Miscellaneous (1)
  9. Review (1)
Groups
  1. Department of Medicine (2292)
  2. Solid Tumor Oncology Division (1376)
  3. GSK Faculty (1135)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (867)
  6. Center for Hematologic Malignancies (861)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5214)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (692)
  2. American Society of Clinical Oncology (604)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (295)
  6. American Society of Hematology (273)

More Publishers

Results (5214)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of exercise on psychological burden in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Tonorezos, E. S.; Ford, J.; Wang, L.; Ness, K. K.; Yasui, Y.; Leisenring, W. M.; Sklar, C. A.; Robison, L. L.; Oeffinger, K. C.; Nathan, P. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Poly(ADP-Ribose) Polymerase Inhibitors (PARPi) for patients (pts) with locally advanced or metastatic breast cancer (BC): A meta-analysis
    Meeting Abstract

    Tio, M.; Patil, S.; Traina, T. A.; Robson, M. E.; Khasraw, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Updated efficacy, safety, & PD-L1 status of patients with HR+, HER2-metastatic breast cancer administered abemaciclib plus pembrolizumab
    Meeting Abstract

    Tolaney, S. M.; Kabos, P.; Dickler, M. N.; Gianni, L.; Jansen, V.; Lu, Y.; Young, S.; Rugo, H. S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Impact of abemaciclib on the time to subsequent chemotherapy and the time to second disease progression across the MONARCH 2 and 3 studies
    Meeting Abstract

    Tolaney, S. M.; Di Leo, A.; Llombart Cussac, A.; Dickler, M. N.; Campone, M.; Iwata, H.; Toi, M.; Kaufman, P. A.; Andre, V. A. M.; Barriga, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Nivolumab (Nivo) as neoadjuvant therapy in patients with resectable Merkel cell carcinoma (MCC) in CheckMate 358
    Meeting Abstract

    Topalian, S. L.; Bhatia, S.; Kudchadkar, R. R.; Amin, A.; Sharfman, W. H.; Lebbe, C.; Delord, J. P.; Shinohara, M. M.; Baxi, S. S.; Chung, C. H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of genomic biomarkers of response to immunotherapy in sarcoma
    Meeting Abstract

    Trabucco, S. E.; Ali, S. M.; Sokol, E.; Betzig Schrock, A.; Albacker, L. A.; Chung, J.; Feldman Xavier, M.; Disel, U.; Miller, V. A.; Ross, J. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pegilodecakin with nivolumab (nivo) or pembrolizumab (pembro) in patients (pts) with metastatic renal cell carcinoma (RCC)
    Meeting Abstract

    Tannir, N. M.; Naing, A.; Infante, J. R.; Papadopoulos, K. P.; Wong, D. J. L.; Korn, M.; Aljumaily, R.; Autio, K. A.; Pant, S.; Bauer, T. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PRECISE: A clinical-grade automated molecular eligibility screening and just-in-time (JIT) physician decision support solution for molecularly-selected oncology trials
    Meeting Abstract

    Tao, J.; Eubank, M. H.; Pamer, E.; Cangemi, N. A.; Drilon, A. E.; Harding, J. J.; Schram, A. M.; Smyth, L. M.; Jhaveri, K. L.; Li, B. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II study of lenvatinib in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Tran, C.; Katabi, N.; Ni, A.; Haque, S.; Pfister, D. G.; Ho, A. L.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Racial, age, and sex disparities in chronic lymphocytic leukemia (CLL) patients treated with novel therapies
    Meeting Abstract

    Thompson, M.; Nabhan, C.; Cheson, B. D.; Allan, J. N.; Barr, P. M.; Skarbnik, A. P.; Jacobs, R.; Ujjani, C. S.; Furman, R. R.; Schuster, S. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save